PI4KB and cancer: Notably, PI4KB-Peptide-1 also suppressed cell proliferation in these cancer cells and exhibited comparable inhibitory effects on proliferation to chloroquine, a clinically used lysosomal inhibitor for autophagy inhibition, when combined with trametinib (Fig. 8h).